Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This Year
26. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
Medical Marijuana, Inc. Investment – AXIM Biotech – Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview
25. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies,...
Medical Marijuana, Inc.’s HempMeds® México Offers Details for Importation of RSHO-X When Purchased in the U.S.
24. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 24, 2016 (GLOBE NEWSWIRE) -- Mexico’s Health Department, COFEPRIS, issued several import permits allowing an individual access to the product called Real Scientific Hemp Oil-X™...
Medical Marijuana, Inc.’s Zero-THC Cannabidiol (CBD) Hemp Oil, RSHO-X™ From HempMeds®, Featured at Southwest Cannabis Conference in Fort Worth, TX
22. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 22, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc.’s (OTC Pink:MJNA) HempMeds® is pleased to announce from the Southwest Cannabis Conference and Expo in Fort Worth, Texas, its...
Medical Marijuana, Inc.旗下投资组合公司Kannalife Sciences, Inc.的KLS-13019研究成果获美国化学学会发表，KLS-13019是针对肝性脑病的一种创新大麻二酚衍生性目标候选药物
19. Februar 2016 01:20 ET
|
Medical Marijuana Inc
圣地亚哥, Feb. 19, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink: MJNA)欣然宣布公司旗下的投资组合公司Kannalife Sciences, Inc....
La empresa de inversión de cartera Kannalife Sciences, Inc. de Medical Marijuana, Inc. logra una publicación a través de la American Chemical Society por la KLS-13019, un nuevo fármaco objeto derivado del cannabidiol candidato para el tratamiento de la encefalopatía hepática
19. Februar 2016 01:20 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 19, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) se complace en anunciar que la empresa de inversiones de cartera de la compañía, Kannalife Sciences, Inc....
Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy
18. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
Medical Marijuana, Inc.'s RSHO-X Garners FOX 5, Other Global News Coverage After News of Historic Import Permits for Mexican Families
12. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 12, 2016 (GLOBE NEWSWIRE) -- As reported by multiple Mexico and U.S.-based news agencies, the country of Mexico is embracing the ability of its residents to access, import and use...
Diretor presidente da Medical Marijuana Inc. apresenta uma palestra de abertura histórica sobre o canabidiol (CBD), no VII Congresso Mundial Antienvelhecimento da Cidade do México
11. Februar 2016 12:44 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 11, 2016 (GLOBE NEWSWIRE) -- A Medical Marijuana, Inc. (OTC Pink:MJNA) tem o prazer de informar a seus acionistas e ao público em geral que seu diretor presidente, Dr....
El director ejecutivo de Medical Marijuana Inc. dará un discurso inaugural histórico sobre el cannabidiol (CBD) en el VII Congreso Mundial en Medicina Antienvejecimiento en Ciudad de México
11. Februar 2016 12:44 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 11, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) se complace en informar a los accionistas y al público en general que el director ejecutivo de la Compañía,...